RESUMEN
BACKGROUND: Beta-2 adrenergic receptor (ADRB2) mediates proliferation and treatment resistance in preclinical models of human epidermal growth factor receptor 2 positive (HER2+) breast cancer. We evaluated ADRB2 gene expression as a prognostic and predictive biomarker in patients with HER2+ early breast cancer. METHODS: ADRB2 expression was retrieved from HER2+ patients enrolled in the FinHer study (N = 202), and 2 public datasets containing data from patients with HER2+ early breast cancer: one including patients who did not receive systemic treatment (disease-free survival [DFS] dataset; n = 175) and another including patients who received neoadjuvant treatment (pathologic complete response [pCR] dataset; n = 207). Survival was estimated with Kaplan-Meier method and Cox regression was used for uni-multivariate analyses. ADRB2 expression was correlated with several gene signatures. RESULTS: ADRB2 high expression was associated with improved DFS rates in HER2+ patients (hazard ratio [HR] 0.52; 95% confidence interval [CI] 0.32-0.84; P = .0068). No association between ADRB2 expression and pCR was observed (odds ratio 1.14; 95% CI, 0.63-2.10; P = .67). No association between ADRB2 and relapse-free survival (RFS) was observed in HER2+ patients enrolled in the FinHer study (HR 0.93; 95% CI, 0.69-1.25; P = .61). ADRB2 was associated with a low expression of angiogenesis-related (vascular endothelial growth factor -0.38, P < .001) and proliferation-related (aurora kinase A -0.36, P < .001; genomic grade index -0.028, P < .001; signal transducers and activators of transcription -0.17, P < .001) genes; and a high expression of immune-related genes (Perez +0.45, P < .001; STAT1 +0.28, P < .001; immune response gene expression module +0.29, P < .001). CONCLUSIONS: Opposing our initial hypothesis, a high ADRB2 expression may be a favorable prognostic factor in patients with HER2+ early breast cancer. This association appears to be mediated by antiproliferative, antiangiogenic, and immunogenic effects of ADRB2.
Asunto(s)
Biomarcadores de Tumor/genética , Neoplasias de la Mama/genética , Mama/patología , Recurrencia Local de Neoplasia/epidemiología , Receptores Adrenérgicos beta 2/genética , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/metabolismo , Mama/cirugía , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/terapia , Quimioterapia Adyuvante/métodos , Conjuntos de Datos como Asunto , Supervivencia sin Enfermedad , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Estimación de Kaplan-Meier , Mastectomía , Persona de Mediana Edad , Terapia Neoadyuvante/métodos , Recurrencia Local de Neoplasia/genética , Recurrencia Local de Neoplasia/patología , Valor Predictivo de las Pruebas , Pronóstico , Factores Protectores , Receptor ErbB-2/análisis , Receptor ErbB-2/metabolismo , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/metabolismo , Receptores de Estrógenos/análisis , Receptores de Estrógenos/metabolismo , Receptores de Progesterona/análisis , Receptores de Progesterona/metabolismo , Medición de Riesgo/métodosRESUMEN
Nonalcoholic fatty liver disease (NAFLD) is very prevalent worldwide and is associated with insulin resistance and metabolic syndrome. Stress is a physiological and biological response to maintain homeostasis of the body against stressors while severe stress response is an important contributor to various illnesses, including metabolic syndrome and brain disorders. We have evaluated the effects of intermittent restraint stress on NAFLD in a high-fat diet (HFD)-fed mouse model. C57/BL6 mice had free access to a 60% HFD for 8 wk, with or without intermittent restraint stress (3 h) conducted three times a week. HFD administration increased fat accumulation in liver tissues. Unlike the stressed standard diet group, the levels of hepatic total cholesterol and triglycerides were significantly ameliorated in the HFD with stress group compared with the HFD alone group. These beneficial results were in accordance with serum levels of liver enzymes (aspartate transaminase, alanine transaminase) and hepatic levels of TNF-α and oxidative stress parameters (reactive oxygen species, nitric oxide, and malondialdehyde). The intermittent restraint stress significantly attenuated the HFD-derived alterations in serum insulin levels, hepatic protein kinase B activity, and gene expression, especially related to lipogenesis. This intermittent restraint stress also elevated the serum epinephrine concentration and activated the adrenergic receptor ß2 or ß3 in livers or white adipose tissue (WAT). Activation of energy expenditure markers (uncoupling protein 1, peroxisome proliferator-activated receptor-γ coactivator-1α) in brown adipose tissue and the browning of WAT were also observed in the HFD with stress group. Taken together, our findings showed the beneficial effects of sympathetic activation by intermittent restraint stress on HFD-induced hepatic steatosis and partial inflammation.NEW & NOTEWORTHY In modern society, stress is a part of daily life, and a certain level of stress is inevitable to most of the general population. Uncontrolled severe stress is obviously harmful; however, certain kind/level of stress could be beneficial on lipid metabolism via sympathetic activation. Our data suggest that a sympathetic activation by intermittent restraint stress could play a positive role in maintaining the balance of hepatic lipid metabolism, especially under high-fat diet conditions.
Asunto(s)
Inflamación/metabolismo , Lipogénesis/fisiología , Hígado/metabolismo , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Estrés Fisiológico/fisiología , Sistema Nervioso Simpático/fisiología , Tejido Adiposo/metabolismo , Animales , Colesterol/metabolismo , Dieta Alta en Grasa/efectos adversos , Ratones , Ratones Endogámicos C57BL , Receptores Adrenérgicos beta 2/análisis , Triglicéridos/metabolismoRESUMEN
BACKGROUND: Melanoma is a life-threatening group of cancers mainly affecting the skin (cutaneous melanoma, CM) and the eyes (uveal melanoma, UM). Nearly half of patients with UM develop liver metastases regardless of the primary treatment. For this reason, adjuvant therapy to prevent disease progression is essential to improve survival of patients with melanoma. Beta-adrenoceptors (ß-AR) have emerged as novel targets to inhibit tumor growth and dissemination in CM, but have not been investigated in UM. METHODS: The aim of this study was to comprehensively evaluate the effects of a non-selective ß-blocker in UM and CM. Propranolol was tested on four UM and two CM cell lines to determine the effects of this beta-blocker. The expression of ß-AR in UM was assessed in enucleated eyes of 36 patients. RESULTS: The results showed that propranolol exerts potent anti-proliferative effects, attenuates migration, reduces VEGF and induces cell cycle arrest and apoptosis in both UM and CM in a dose-dependent manner. Furthermore, levels of cell-free DNA released from the cells correlated to propranolol treatment and may be an indicator of treatment response. Finally, immunohistochemical analysis revealed the expression of ß1 and ß2 adrenoceptors in all UM patients, with higher expression seen in the more aggressive epithelioid versus less aggressive spindle cells. CONCLUSIONS: Collectively our data suggest that a nonselective beta-blocker may be effective against melanoma. For the first time, we show potent anti-tumor effects in UM cells following propranolol administration and expression of ß1 and ß2 adrenoceptors in patient tissue.
Asunto(s)
Antagonistas Adrenérgicos beta/farmacología , Melanoma/tratamiento farmacológico , Propranolol/farmacología , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias de la Úvea/tratamiento farmacológico , Antagonistas Adrenérgicos beta/uso terapéutico , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Melanoma/patología , Melanoma/cirugía , Cultivo Primario de Células , Propranolol/uso terapéutico , Receptores Adrenérgicos beta 1/análisis , Receptores Adrenérgicos beta 1/metabolismo , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/metabolismo , Neoplasias Cutáneas/patología , Úvea/patología , Úvea/cirugía , Neoplasias de la Úvea/patología , Neoplasias de la Úvea/cirugíaRESUMEN
Stress decreases milk components such as milk protein and milk yield. The objective of this study was to investigate whether noradrenaline (NA) in milk constituted a factor associated with stress-induced changes in milk proteins such as ß-casein. Breast milk obtained from eight healthy, nursing women contained NA at concentrations ranging from 12.7 to 115.5 nM. The expression of tyrosine hydroxylase (TH), a rate-limiting enzyme of NA synthesis, was observed in primary normal human mammary epithelial cells (HMECs), and in MCF-12A and MCF-10A cell lines. The mean NA concentration in culture medium used by MCF-12A transfected with TH small interfering RNA (siRNA) was significantly lower than that of cells transfected with control siRNA. NA concentration in milk in restraint-stressed nursing mice was significantly higher than that in nonstressed nursing mice, owing to elevated TH expression in the mammary epithelium. The mean ß-casein concentration in milk in restraint-stressed mice was significantly lower than that in nonstressed mice. NA treatment resulted in a concentration-dependent decrease in ß-casein expression in HMECs. ß2 adrenergic receptor (ADRB2) expression was observed in HMECs, MCF-12A, and MCF-10A, and immunohistochemical analysis of ADRB2 using mammary epithelium sections obtained from mice at day 10 of lactation showed that ADRB2 was expressed at the apical membrane of mammary epithelium. Treatment with salbutamol, an ADRB2 stimulant, decreased ß-casein expression in a concentration-dependent manner in MCF-12A. Our results showed that endogenous NA derived from mammary epithelial cells likely comprises one of the factors involved in stress-induced changes in milk proteins such as ß-casein.
Asunto(s)
Caseínas/análisis , Leche/química , Norepinefrina/fisiología , Estrés Psicológico/metabolismo , Adulto , Animales , Mama/metabolismo , Células Cultivadas , Femenino , Humanos , Ratones , Embarazo , Receptores Adrenérgicos beta 2/análisis , Tirosina 3-Monooxigenasa/genéticaRESUMEN
AIMS: Breast cancer is the most frequently diagnosed and leading cause of cancer death among women worldwide. It was classified within molecular intrinsic subtypes: luminal A, luminal B, human epidermal growth factor receptor 2-enriched and basal-like. Epinephrine and norepinephrine, released during stress, bind to adrenoceptors. α2 -adrenoceptors are encoded by the ADRA2A, ADRA2B and ADRA2C genes and ß2 by ADRB2. METHODS: We compiled several publicly available Affymetrix gene expression datasets, obtaining a large cohort of 1924 patients with distant metastasis-free survival (DMFS) data and evaluated the association between adrenoceptor expression, clinicopathological markers and outcome. RESULTS: ADRA2A high expressing tumours also expressed hormone receptors and presented diminished tumour size, grade and not compromised lymph nodes. ADRB2 high expression was found in smaller, low grade, oestrogen receptor-positive tumours. Both were significantly associated with the absence of metastasis. High expression of ADRA2C was positively associated with increased tumour size and metastatic relapse. We observed a significant increase in DMFS of patients with high ADRA2A (hazard ratio 0.54, 95% CI 0.45-0.65, P < .001) and ADRB2 (0.77, 0.64-0.93, P = .006) expression and a decrease with ADRA2C high expression (1.45, 1.16-1.81, P = .001). For patients with luminal tumours, ADRA2A was the only factor that retained its significance as an independent predictor of DMFS while ADRA2C expression was an independent predictor for worse prognosis in basal-like tumours. CONCLUSIONS: We herein provide new insight for a potential role of ADRA2A and ADRA2C in breast cancer. In low- and medium-income countries, their incorporation to routine immunohistochemistry analysis of biopsies or tumour samples, could provide additional low-cost prognostic factors.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/patología , Receptores Adrenérgicos alfa 2/metabolismo , Biomarcadores de Tumor/análisis , Mama/patología , Neoplasias de la Mama/mortalidad , Conjuntos de Datos como Asunto , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Perfilación de la Expresión Génica , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Análisis de Secuencia por Matrices de Oligonucleótidos , Pronóstico , Receptores Adrenérgicos alfa 2/análisis , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/metabolismoRESUMEN
The past decade has witnessed the great promise of strategies for ligand discovery based on surface-immobilized GPCRs. We present here a method for preparation of immobilized GPCRs. Key features include covalent immobilization with high specificity and robust application in drug-receptor interaction analysis and ligand screening. In our example assay using beta2-adrenergic receptor (ß2-AR), the human DNA repair protein O6-alkylguanine-DNA alkyltransferase (hAGT) fusion receptor expressed in Escherichia coli was directly captured onto polyethylene glycol polyacrylamide (PEGA) resin. We observed even distribution and physiological functions of ß2-AR on the resin. The immobilized ß2-AR as a stationary phase enabled us to rapidly determine the binding of four drugs to ß2-AR. By coupling this assay to mass spectrometry, we screened rosmarinic acid as a bioactive compound targeting ß2-AR in Fructus Perillae. We concluded that O6-benzylguanine derivative-functionalized supporter is promising for specific immobilization of hAGT-tagged proteins; immobilized receptor chromatography has great potential in screening receptor-binding leads from herbal plants or traditional medicine recipes.
Asunto(s)
Cinamatos/farmacología , Depsidos/farmacología , Descubrimiento de Drogas , Guanina/análogos & derivados , Ensayos Analíticos de Alto Rendimiento , Receptores Adrenérgicos beta 2/metabolismo , Cinamatos/química , Depsidos/química , Guanina/química , Guanina/metabolismo , Humanos , Ligandos , Perilla/química , Receptores Adrenérgicos beta 2/análisis , Propiedades de Superficie , Ácido RosmarínicoRESUMEN
Fast, high-yielding, and selective bioorthogonal "click" reactions employing nontoxic reagents are in high demand for their great utility in the conjugation of biomolecules in live cells. Although a number of click reactions were developed for this purpose, many are associated with drawbacks and limitations that justify the development of alternative systems for both single- or dual-labeling applications. Recent reports have highlighted the potential of boronic ester formation as a bioorthogonal click reaction between abiotic boronic acids and diols. Boronic ester formation is a fast dehydrative process; however it is intrinsically reversible in aqueous medium. We designed and optimized a synergic system based on two bifunctional reagents, a thiosemicarbazide-functionalized nopoldiol and an ortho-acetyl arylboronic acid. Both reagents were shown to be chemically stable and nontoxic to HEK293T cells at concentrations as high as 50 µM. The resulting boronate/thiosemicarbazone adduct is a medium-sized ring that forms rapidly and irreversibly without any catalyst at low µM concentrations, in neutral buffer, with a rate constant of 9 M-1 s-1 as measured by NMR spectroscopy. Control experiments in the presence of competing boronic acids showed no crossover side-products and confirmed the stability and lack of reversibility of the boronate/thiosemicarbazone conjugates. Formation of the conjugates is not affected by the presence of biological diols such as fructose, glucose, and catechol, and the thiosemicarbazide-functionalized nopoldiol is inert to aldehyde electrophiles of the sort found on protein-bound glyoxylyl units. The suitability of this system in the cell-surface labeling of live cells was demonstrated using a SNAP-tag approach to install the boronic acid reagent onto the extracellular domain of the Beta-2 adrenergic receptor in HEK293T cells, followed by incubation with the optimal thiosemicarbazide-functionalized nopoldiol reagent labeled with fluorescein dye. Successful visualization by fluorescence microscopy was possible with a reagent concentration as low as 10 µM, thus confirming the potential of this system in biological applications.
Asunto(s)
Ácidos Borónicos/química , Química Clic/métodos , Colorantes Fluorescentes/química , Receptores Adrenérgicos beta 2/análisis , Tiosemicarbazonas/química , Ácidos Borónicos/síntesis química , Supervivencia Celular , Colorantes Fluorescentes/síntesis química , Células HEK293 , Humanos , Imagen Óptica/métodos , Coloración y Etiquetado/métodos , Tiosemicarbazonas/síntesis químicaRESUMEN
OBJECTIVE: To identify novel combinations of genetic and psychological factors that predicted 12-month postoperative pain and disability outcomes following arthroscopic shoulder surgery. METHODS: A prospective presurgical cohort (n = 150) was recruited to complete validated psychological questionnaires and have their DNA collected from saliva. DNA was genotyped for a priori selected genes involved with pain modulation (ADRB2, OPRM1, AVPR1A, GCH1, and KCNS1) and inflammation (IL1B, TNF/LTA, and IL6). The outcome measures of interest were the Brief Pain Inventory and Disabilities of the Arm, Shoulder, and Hand questionnaire. Followup for the cohort was at 3, 6, and 12 months postoperatively. After controlling for age, sex, race, and preoperative status, genetic and psychological factors were entered as main effects and interaction terms in separate general linear models for predicting postoperative pain and disability outcomes. RESULTS: Seven interactions involving pain-modulatory genes were identified. Three provided strong statistical evidence for different outcomes, including KCNS1 and kinesiophobia for preoperative pain intensity, ADRB2 and depressive symptoms for postoperative course, and GCH1 and anxiety symptoms for 12-month pain-intensity outcome. Ten interactions involving inflammatory genes were identified. Three provided strong statistical evidence for the 12-month postoperative course outcome, including 2 different IL6 single-nucleotide polymorphism and pain catastrophizing, and IL6 and depressive symptoms. CONCLUSION: The current study identified novel genetic and psychological interactions that can be used in future studies to further understand the development of persistent postoperative pain and investigate the effectiveness of tailored treatment.
Asunto(s)
Artroscopía/efectos adversos , Dolor Postoperatorio/genética , Dolor Postoperatorio/psicología , Dolor de Hombro/genética , Dolor de Hombro/psicología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Ansiedad/genética , Ansiedad/psicología , Catastrofización/genética , Catastrofización/psicología , Depresión/genética , Depresión/psicología , Evaluación de la Discapacidad , Femenino , Estudios de Seguimiento , GTP Ciclohidrolasa/análisis , Humanos , Interleucina-6/análisis , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Dolor Postoperatorio/fisiopatología , Polimorfismo de Nucleótido Simple , Canales de Potasio con Entrada de Voltaje/análisis , Estudios Prospectivos , Receptores Adrenérgicos beta 2/análisis , Hombro/cirugía , Dolor de Hombro/fisiopatología , Encuestas y Cuestionarios , Factores de Tiempo , Resultado del Tratamiento , Adulto JovenRESUMEN
BACKGROUND: Asthma is a complex disease influenced by multiple genetic and environmental factors. While Madeira has the highest prevalence of asthma in Portugal (14.6%), the effect of both genetic and environmental factors in this population has never been assessed. We categorized 98 asthma patients according to the Global Initiative for Asthma (GINA) guidelines, established their sensitization profile, and measured their forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) indexes. Selected single nucleotide polymorphisms (SNPs) were analysed as potential markers for asthma susceptibility and severity in the interleukin 4 (IL4), interleukin 13 (IL13), beta-2-adrenergic receptor (ADRB2), a disintegrin and metalloprotease 33 (ADAM33), gasdermin-like (GSDML) and the signal transducer and activator of transcription 6 (STAT6) genes comparatively to a population reference set. RESULTS: Although mites are the major source of allergic sensitization, no significant difference was found amongst asthma severity categories. IL4-590*CT/TT and IL4-RP2*253183/183183 were found to predict the risk (2-fold) and severity (3 to 4-fold) of asthma and were associated with a lower FEV1 index. ADRB2-c.16*AG is a risk factor (3.5-fold), while genotype GSDML-236*TT was protective (4-fold) for moderate-severe asthma. ADAM33-V4*C was associated to asthma and mild asthma by the transmission disequilibrium test (TDT). Finally, ADAM33-V4*CC and STAT6-21*TT were associated with higher sensitization (mean wheal size ≥10 mm) to house dust (1.4-fold) and storage mite (7.8-fold). CONCLUSION: In Madeira, IL4-590C/T, IL4-RP2 253/183, GSDML-236C/T and ADAM33-V4C/G SNPs are important risk factors for asthma susceptibility and severity, with implications for asthma healthcare management.
Asunto(s)
Asma/genética , Polimorfismo Genético/genética , Proteínas ADAM/análisis , Proteínas ADAM/genética , Adolescente , Biomarcadores , Estudios de Casos y Controles , Niño , Desintegrinas/análisis , Desintegrinas/genética , Femenino , Volumen Espiratorio Forzado/genética , Genotipo , Humanos , Interleucina-13/análisis , Interleucina-13/genética , Interleucina-4/análisis , Interleucina-4/genética , Masculino , Proteínas de Neoplasias/análisis , Proteínas de Neoplasias/genética , Polimorfismo de Nucleótido Simple/genética , Portugal , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/genética , Factores de Riesgo , Factor de Transcripción STAT6/análisis , Factor de Transcripción STAT6/genética , Índice de Severidad de la Enfermedad , Estadísticas no Paramétricas , Capacidad Vital/genéticaRESUMEN
Infectious complications are the leading cause of death in the post-acute phase of stroke. Post-stroke immunodeficiency is believed to result from neurohormonal dysregulation of the sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) axis. However, the differential effects of these neuroendocrine systems on the peripheral immune cells are only partially understood. Here, we determined the impact of the hormones of the SNS and HPA on distinct immune cell populations and characterized their interactions after stroke. At various time points after cortical or extensive hemispheric cerebral ischemia, plasma cortisone, corticosterone, metanephrine and adrenocorticotropic hormone (ACTH) levels were measured in mice. Leukocyte subpopulations were flow cytometrically analyzed in spleen and blood. To investigate their differential sensitivity to stress hormones, splenocytes were incubated in vitro with prednisolone, epinephrine and their respective receptor blockers. Glucocorticoid receptor (GCR) and beta2-adrenergic receptor (ß2-AR) on leukocyte subpopulations were quantified by flow cytometry. In vivo effects of GCR and selective ß2-AR blockade, respectively, were defined on serum hormone concentrations, lymphopenia and interferon-γ production after severe ischemia. We found elevated cortisone, corticosterone and metanephrine levels and associated lymphocytopenia only after extensive brain infarction. Prednisolone resulted in a 5 times higher cell death rate of splenocytes than epinephrine in vitro. Prednisolone and epinephrine-induced leukocyte cell death was prevented by GCR and ß2-AR blockade, respectively. In vivo, only GCR blockade prevented post ischemic lymphopenia whereas ß2-AR preserved interferon-γ secretion by lymphocytes. GCR blockade increased metanephrine levels in vivo and prednisolone, in turn, decreased ß2-AR expression on lymphocytes. In conclusion, mediators of the SNS and the HPA axis differentially affect the systemic immune system after stroke. Moreover, our findings suggest a negative-feedback of corticosteroids on the sympathetic axis which may control the post-stroke stress-reaction. This complex interplay between the HPA and the SNS after stroke has to be considered when targeting the neurohormonal systems in the post acute phase of severe stroke.
Asunto(s)
Sistema Hipotálamo-Hipofisario/fisiopatología , Infarto de la Arteria Cerebral Media/inmunología , Neuroinmunomodulación/fisiología , Sistema Hipófiso-Suprarrenal/fisiopatología , Sistema Nervioso Simpático/fisiopatología , Animales , Apoptosis/efectos de los fármacos , Células Cultivadas , Corticosterona/sangre , Cortisona/sangre , Epinefrina/farmacología , Retroalimentación Fisiológica , Infarto de la Arteria Cerebral Media/sangre , Infarto de la Arteria Cerebral Media/fisiopatología , Interferón gamma/biosíntesis , Leucocitos/citología , Leucocitos/efectos de los fármacos , Linfopenia/etiología , Masculino , Metanefrina/sangre , Ratones , Ratones Endogámicos C57BL , Mifepristona/farmacología , Neuroinmunomodulación/efectos de los fármacos , Prednisolona/farmacología , Propanolaminas/farmacología , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/biosíntesis , Receptores Adrenérgicos beta 2/efectos de los fármacos , Receptores de Glucocorticoides/análisis , Receptores de Glucocorticoides/antagonistas & inhibidoresRESUMEN
BACKGROUND: Asthma is a complex disease influenced by multiple genetic and environmental factors. While Madeira has the highest prevalence of asthma in Portugal (14.6%), the effect of both genetic and environmental factors in this population has never been assessed. We categorized 98 asthma patients according to the Global Initiative for Asthma (GINA) guidelines, established their sensitization profile, and measured their forced expiratory volume in 1second (FEV1) and forced vital capacity (FVC) indexes. Selected single nucleotide polymorphisms (SNPs) were analysed as potential markers for asthma susceptibility and severity in the interleukin 4 (IL4), interleukin 13 (IL13), beta-2-adrenergic receptor (ADRB2), a disintegrin and metalloprotease 33 (ADAM33), gasdermin-like (GSDML) and the signal transducer and activator of transcription 6 (STAT6) genes comparatively to a population reference set. RESULTS: Although mites are the major source of allergic sensitization, no significant difference was found amongst asthma severity categories. IL4-590*CT/TT and IL4-RP2*253183/183183 were found to predict the risk (2-fold) and severity (3 to 4-fold) of asthma and were associated with a lower FEV1 index. ADRB2-c.16*AG is a risk factor (3.5-fold), while genotype GSDML-236*TT was protective (4-fold) for moderate-severe asthma. ADAM33-V4*C was associated to asthma and mild asthma by the transmission disequilibrium test (TDT). Finally, ADAM33-V4*CC and STAT6-21*TT were associated with higher sensitization (mean wheal size ≥10mm) to house dust (1.4-fold) and storage mite (7.8-fold). CONCLUSION: In Madeira, IL4-590C/T, IL4-RP2 253/183, GSDML-236C/T and ADAM33-V4C/G SNPs are important risk factors for asthma susceptibility and severity, with implications for asthma healthcare management.
Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Polimorfismo Genético/genética , Asma/genética , Portugal , Índice de Severidad de la Enfermedad , Biomarcadores , Estudios de Casos y Controles , Capacidad Vital/genética , Volumen Espiratorio Forzado/genética , Factores de Riesgo , Interleucina-4/análisis , Interleucina-4/genética , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/genética , Estadísticas no Paramétricas , Interleucina-13/análisis , Interleucina-13/genética , Desintegrinas/análisis , Desintegrinas/genética , Polimorfismo de Nucleótido Simple/genética , Proteínas ADAM/análisis , Proteínas ADAM/genética , Factor de Transcripción STAT6/análisis , Factor de Transcripción STAT6/genética , Genotipo , Proteínas de Neoplasias/análisis , Proteínas de Neoplasias/genéticaRESUMEN
Stress and sex hormones are known to regulate immune function. Castration of male piglets is used to avoid boar taint in the meat, but its consequences on immunity and health of male pigs are poorly known. In this study, intact and neonatally surgically castrated male pigs (n=20 per group) were compared along puberty for some immune parameters and hormone receptor expression in lymphoid organs. Pigs were immunised with keyhole limpet haemocyanin (KLH) at 113 and 133 days of age. Blood lymphocyte numbers and proliferation, immunoglobulin titres, haptoglobin and hormone levels at 89, 119 and 152 days and the mRNA expression of androgen, α-oestrogen, glucocorticoid and ß2-adrenergic receptors in liver, spleen and thymus at 160 days were assessed. Blood lymphocyte numbers were lower (at 119 and 152 days) and total IgG and haptoglobin concentrations were higher (at 152 days) in castrated than intact males. The concanavalin A and KLH proliferation responses and anti-KLH IgG titres were not altered. At slaughter, intact pigs presented a heavier thymus and a lower hepatic expression of ß2-adrenergic receptor. In conclusion, the effects of neonatal castration were moderate. Other studies are needed to clarify the possible detrimental outcomes of castration on lymphocyte numbers and thymic growth.
Asunto(s)
Biomarcadores/sangre , Castración/veterinaria , Indicadores de Salud , Porcinos/fisiología , Animales , Animales Recién Nacidos , Castración/estadística & datos numéricos , Haptoglobinas/análisis , Hemocianinas/administración & dosificación , Inmunoglobulina G/sangre , Hígado/metabolismo , Recuento de Linfocitos/veterinaria , Masculino , Tamaño de los Órganos , Receptores Adrenérgicos beta 2/análisis , Porcinos/inmunología , Timo/crecimiento & desarrolloRESUMEN
BACKGROUND/AIMS: Beta-adrenoceptor is considered to be an important modulator of smooth muscle function. It is widely present in the mammalian gastrointestinal tract and nervous system. The aim of this study was to explore the expression of 1-adrenoceptors (ß1-AR, ß2-AR, ß3-AR) in sling fibers and clasp fibers from human lower esophageal sphincter (LES). METHODOLOGY: Sling and clasp fibers from the LES were obtained from patients undergoing esophagogastrectomy; circular muscle strips from the esophagus and stomach were used as controls. Reverse transcription-polymerase chain reaction and western blotting were used to determine the expression of the three subtypes of ß-adrenoceptors. RESULTS: Messenger RNA and protein for three subtypes of ß-adrenoceptors were all identified in the sling and clasp fibers of the LES. Expression was highest for ß3-AR, then ß1-AR and ß2-AR in decreasing levels. CONCLUSIONS: ß1-AR, ß2-AR, ß3-AR can be detected in human lower esophageal sphincter and contribute to LES function.
Asunto(s)
Esfínter Esofágico Inferior/química , Receptores Adrenérgicos beta/análisis , Anciano , Western Blotting , Esfínter Esofágico Inferior/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , ARN Mensajero/análisis , Receptores Adrenérgicos beta/genética , Receptores Adrenérgicos beta 1/análisis , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 3/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
Trafficking and localization of G protein-coupled receptors (GPCRs) to the plasma membrane and its retention in the agonist-naive state are critically important for signaling by these receptors. Agonist-induced desensitization of activated GPCRs and their removal from the cell surface have been studied and reviewed extensively. However, less attention has been given to the regulatory mechanisms and different steps that control the trafficking of newly synthesized receptors to the plasma membrane. It is generally believed that the mRNAs encoding GPCRs are targeted to the endoplasmic reticulum by a cotranslational, signal-sequence recognition particle-dependent pathway that results in protein translation and translocation to the plasma membrane. In this chapter, we discuss the importance of cis-targeting elements and trans-recognition factors in GPCR mRNA translational silencing, trafficking, and localization within the cell and its importance in receptor trafficking to the plasma membrane. Knockdown of the critical trans-recognition factors (RNA-binding proteins) resulted in translation of GPCR mRNAs in the perinuclear region and the receptors failed to traffic to the plasma membrane. Thus, a new paradigm is emerging in GPCR trafficking that suggests a fundamental role for mRNA partitioning to specific cytoplasmic regions for efficient plasma membrane localization of the receptors.
Asunto(s)
Membrana Celular/metabolismo , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/metabolismo , Animales , Técnicas Citológicas/métodos , Proteínas ELAV/análisis , Proteínas ELAV/metabolismo , Electroforesis en Gel de Poliacrilamida/métodos , Regulación de la Expresión Génica , Humanos , Transporte de Proteínas , ARN Mensajero/genética , Proteínas de Unión al ARN/análisis , Proteínas de Unión al ARN/metabolismo , Receptores Adrenérgicos beta 2/genéticaRESUMEN
Coat protein complex II (COPII) vesicle-mediated protein export from the endoplasmic reticulum (ER) can be controlled by linear, independent motifs embedded within the cargo. ER export motifs directly interact with selective components of COPII vesicles and enhance cargo recruitment onto COPII vesicles. Moreover, ER export motifs are able to confer their transport abilities to other proteins. We have recently identified a novel ER export motif for α(2B)-adrenergic receptor (α(2B)-AR). This motif selectively interacts with Sec24C/D isoforms of COPII vesicles and facilitates α(2B)-AR export from the ER as well as transport to the cell surface. This motif can also mediate CD8 glycoprotein transport. These studies indicate that ER export of nascent G protein-coupled receptors (GPCRs) may be directed by specific codes that mediate receptor interaction with the ER-derived COPII vesicles. In this chapter, I discuss experimental approaches to identify ER export motifs for GPCRs by using α(2B)-AR as a model.
Asunto(s)
Vesículas Cubiertas por Proteínas de Revestimiento/metabolismo , Retículo Endoplásmico/metabolismo , Receptores Acoplados a Proteínas G/análisis , Receptores Acoplados a Proteínas G/metabolismo , Secuencia de Aminoácidos , Animales , Vesículas Cubiertas por Proteínas de Revestimiento/química , Retículo Endoplásmico/química , Humanos , Datos de Secuencia Molecular , Transporte de Proteínas , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/metabolismoRESUMEN
The ß2-AR (ß2-adrenergic receptor) is an important target for respiratory and CVD (cardiovascular disease) medications. Clinical studies suggest that N-terminal polymorphisms of ß2-AR may act as disease modifiers. We hypothesized that polymorphisms at amino acids 16 and 27 result in differential trafficking and down-regulation of ß2-AR variants following ß-agonist exposure. The functional consequences of the four possible combinations of these polymorphisms in the human ß2-AR (designated ß2-AR-RE, ß2-AR-GE, ß2-AR-RQ and ß2-AR-GQ) were studied using site-directed mutagenesis and recombinant expression in HEK-293 cells (human embryonic kidney cells). Ligand-binding assays demonstrated that after 24 h exposure to 1 µM isoprenaline, isoforms with Arg16 (ß2-AR-RE and ß2-AR-RQ) underwent increased down-regulation compared with isoforms with Gly16 (ß2-AR-GE and ß2-AR-GQ). Consistent with these differences in down-regulation between isoforms, prolonged isoprenaline treatment resulted in diminished cAMP response to subsequent isoprenaline challenge in ß2-AR-RE relative to ß2-AR-GE. Confocal microscopy revealed that the receptor isoforms had similar co-localization with the early endosomal marker EEA1 following isoprenaline treatment, suggesting that they had similar patterns of internalization. None of the isoforms exhibited significant co-localization with the recycling endosome marker Rab11 in response to isoprenaline treatment. Furthermore, we found that prolonged isoprenaline treatment led to a higher degree of co-localization of ß2-AR-RE with the lysosomal marker LAMP1 (lysosome-associated membrane protein 1) compared with that of ß2-AR-GE. Taken together, these results indicate that a mechanism responsible for differential responses of these receptor isoforms to the ß-agonist involves differences in the efficiency with which agonist-activated receptors are trafficked to the lysosomes for degradation, or differences in degradation in the lysosomes.
Asunto(s)
Agonistas Adrenérgicos beta/farmacología , Regulación hacia Abajo/efectos de los fármacos , Isoproterenol/farmacología , Polimorfismo Genético , Transporte de Proteínas/efectos de los fármacos , Receptores Adrenérgicos beta 2/genética , AMP Cíclico/metabolismo , Células HEK293 , Humanos , Proteína 1 de la Membrana Asociada a los Lisosomas/análisis , Isoformas de Proteínas/análisis , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/metabolismo , Proteínas de Unión al GTP rab/metabolismoRESUMEN
BACKGROUND: Previous studies have demonstrated an important role for beta-2 adrenergic receptors (ß(2)AR) in lung fluid clearance. The purpose of this investigation was to examine the relationship between ß(2)AR density on lymphocytes and indices of lung water in healthy humans exposed to ≈ 17 h of hypoxia (FIO2 = 12.5% in a hypoxia tent). METHODS: Thirteen adults (mean ± SEM; age=31 ± 3 years, BMI=24 ± 1 kg/m(2), VO2 Peak = 40 ± 2 ml/kg/min ) participated. Pulmonary function, CT derived lung tissue volume (V(tis)-tissue, blood and water), lung diffusing capacity for carbon monoxide (D(CO)) and nitric oxide (D(NO)), alveolar-capillary conductance (D(M)), pulmonary capillary blood volume (V(c)) and lung water (CT V(tis)-V(c)) were assessed before and after ≈ 17 h normobaric hypoxia (FIO2 = 12.5%). ß(2)AR density on lymphocytes was measured via radioligand binding. Arterial oxygen saturation (SaO2), cardiac output (Q), right ventricular systolic pressure (RVSP) and blood pressure (BP) were also assessed. RESULTS: After 17 h hypoxia, SaO2 decreased from 97 ± 1 (normoxia) to 82 ± 4% and RVSP increased from 14 ± 3 (normoxia) to 29 ± 2 mmHg (p<0.05) with little change in Q or BP. V(c) and D(M) both increased with hypoxia with a small increase in D(M)/V(c) ratio (p>0.05). CT V(tis) decreased and lung water was estimated to decline 7 ± 13%, respectively. ß(2)AR density averaged 1497 ± 187 receptors/lymphocyte and increased 21 ± 34% with hypoxia (range -31 to +86%). The post-hypoxia increase in ß(2)AR density was significantly related to the reduction in lung water (r=-0.64, p<0.05), with the subjects with the greatest increase in density demonstrating the largest decline in lung water. CONCLUSIONS: Lung water decreases with 17 h normobaric hypoxia are associated with changes in beta adrenergic receptor density on lymphocytes in healthy adults.
Asunto(s)
Pulmón/fisiopatología , Linfocitos/fisiología , Oxígeno/fisiología , Receptores Adrenérgicos beta 2/metabolismo , Equilibrio Hidroelectrolítico/fisiología , Adulto , Presión Sanguínea/fisiología , Monóxido de Carbono/sangre , Monóxido de Carbono/fisiología , Gasto Cardíaco/fisiología , Femenino , Humanos , Masculino , Óxido Nítrico/sangre , Óxido Nítrico/fisiología , Oxígeno/sangre , Consumo de Oxígeno/fisiología , Receptores Adrenérgicos beta 2/análisis , Pruebas de Función Respiratoria , Función Ventricular/fisiologíaRESUMEN
Propranolol has recently emerged as an effective therapy for infantile hemangiomas causing regression. The ß-adrenergic receptor (AR) antagonist is thought to cause vasoconstriction by its effect on nitric oxide, block angiogenesis by its effect on vascular endothelial growth factor (VEGF), and induce apoptosis. In a prior report, we identified expression of ß2-AR (B2-AR) and its phosphorylated form (B2-ARP) in a case of infantile hemangioma that responded to propranolol treatment. We now explore the expression of ßARs on a variety of vascular lesions utilizing a tissue microarray containing 141 lesions, including infantile hemangiomas, angiosarcomas, hemangiomas, hemangioendotheliomas, and various vascular malformations. The array was immunostained for B2-AR, B2-ARP, and ß3-AR (B3-AR), and the results scored for the intensity of endothelial cell expression as negative, weak positive, or strong positive. All phases of infantile hemangiomas had strong expression of all three receptors, with the exception of only weak expression of B2-ARP in the proliferative phase infantile hemangioma. Strong expression of all three receptors was present in many hemangiomas, hemangioendotheliomas, and vascular malformations. Absent to weak expression of all three receptors was seen in glomus tumor, hobnail hemangioendothelioma, pyogenic granuloma, and reactive vascular proliferations. This is the first study to report ß-AR expression in a variety of vascular lesions. Although immunohistochemical expression of the receptors does not necessarily indicate that similar pathways of responsiveness to ß-blockade are present, it does raises the possibility that ß-blockade could potentially affect apoptosis and decrease responsiveness to VEGF. Additional study is warranted, as therapeutic options are limited for some patients with these lesions.
Asunto(s)
Biomarcadores de Tumor/análisis , Neoplasias de Tejido Vascular/química , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 3/análisis , Proliferación Celular , Hemangioendotelioma/química , Hemangioendotelioma/patología , Hemangioma/química , Hemangioma/patología , Hemangiosarcoma/química , Hemangiosarcoma/patología , Humanos , Inmunohistoquímica , Neoplasias de Tejido Vascular/patología , Fosforilación , Análisis de Matrices TisularesRESUMEN
Single-molecule fluorescence measurements allow researchers to study asynchronous dynamics and expose molecule-to-molecule structural and behavioral diversity, which contributes to the understanding of biological macromolecules. To provide measurements that are most consistent with the native environment of biomolecules, researchers would like to conduct these measurements in the solution phase if possible. However, diffusion typically limits the observation time to approximately 1 ms in many solution-phase single-molecule assays. Although surface immobilization is widely used to address this problem, this process can perturb the system being studied and contribute to the observed heterogeneity. Combining the technical capabilities of high-sensitivity single-molecule fluorescence microscopy, real-time feedback control and electrokinetic flow in a microfluidic chamber, we have developed a device called the anti-Brownian electrokinetic (ABEL) trap to significantly prolong the observation time of single biomolecules in solution. We have applied the ABEL trap method to explore the photodynamics and enzymatic properties of a variety of biomolecules in aqueous solution and present four examples: the photosynthetic antenna allophycocyanin, the chaperonin enzyme TRiC, a G protein-coupled receptor protein, and the blue nitrite reductase redox enzyme. These examples illustrate the breadth and depth of information which we can extract in studies of single biomolecules with the ABEL trap. When confined in the ABEL trap, the photosynthetic antenna protein allophycocyanin exhibits rich dynamics both in its emission brightness and its excited state lifetime. As each molecule discontinuously converts from one emission/lifetime level to another in a primarily correlated way, it undergoes a series of state changes. We studied the ATP binding stoichiometry of the multi-subunit chaperonin enzyme TRiC in the ABEL trap by counting the number of hydrolyzed Cy3-ATP using stepwise photobleaching. Unlike ensemble measurements, the observed ATP number distributions depart from the standard cooperativity models. Single copies of detergent-stabilized G protein-coupled receptor proteins labeled with a reporter fluorophore also show discontinuous changes in emission brightness and lifetime, but the various states visited by the single molecules are broadly distributed. As an agonist binds, the distributions shift slightly toward a more rigid conformation of the protein. By recording the emission of a reporter fluorophore which is quenched by reduction of a nearby type I Cu center, we probed the enzymatic cycle of the redox enzyme nitrate reductase. We determined the rate constants of a model of the underlying kinetics through an analysis of the dwell times of the high/low intensity levels of the fluorophore versus nitrite concentration.
Asunto(s)
Microscopía Fluorescente/métodos , Técnicas de Sonda Molecular , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/análisis , Adenosina Trifosfato/metabolismo , Indoles/análisis , Indoles/metabolismo , Canales Iónicos/análisis , Cinética , Microfluídica/instrumentación , Técnicas de Sonda Molecular/instrumentación , Nitrito Reductasas/análisis , Nitrito Reductasas/química , Nitrito Reductasas/metabolismo , Fotoblanqueo , Ficocianina/análisis , Ficocianina/química , Conformación Proteica , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 2/química , Receptores Adrenérgicos beta 2/metabolismo , SolucionesRESUMEN
Methods used to assess the efficacy of potentially therapeutic reagents for G protein-coupled receptors (GPCRs) have been developed. Previously, we demonstrated sensitive detection of the interaction of GPCRs and ß-arrestin2 (ARRB2) using 96-well microtiter plates and a bioluminescence microscope based on split click beetle luciferase complementation. Herein, using firefly luciferase emitting longer wavelength light, we demonstrate quantitative analysis of the interaction of ß2-adrenergic receptor (ADRB2), a kind of GPCR, and ARRB2 in a 96-well plate assay with single-cell imaging. Additionally, we showed bioluminescence in vivo imaging of the ADRB2-ARRB2 interaction in two systems: cell implantation and hydrodynamic tail vein (HTV) methods. Specifically, in the HTV method, the luminescence signal from the liver upon stimulation of an agonist for ADRB2 was obtained in the intact systems of mice. The results demonstrate that this method enables noninvasive screening of the efficacy of chemicals at the specific organ in in vivo testing. This in vivo system can contribute to effective evaluation in pharmacokinetics and pharmacodynamics and expedite the development of new drugs for GPCRs.